Showing Latest Articles
Malignant Peripheral Nerve Sheath Tumors (MPNST): The Mayo Clinic Experience
Annals of Surgical Oncology, 09/07/2011
Stucky CCH et al. – High tumor grade and tumor size >=5 cm predict adverse disease–specific survival (DSS) for malignant peripheral nerve sheath tumors (MPNST). In the context of a multidisciplinary treatment regimen, local recurrence and survival outcomes at 5 and 10 years were better than previously reported for MPNST.